Literature DB >> 3970122

Treatment of blepharospasm with botulinum toxin.

E A Tsoy, E G Buckley, J J Dutton.   

Abstract

In 43 patients (81 eyes) with blepharospasm resistant to other forms of therapy, 149 outpatient injections of botulinum A toxin were given into the orbicularis oculi muscle. Subsequent follow-up periods ranged from ten to 210 days. Orbicularis oculi spasm, eyelid forced closure, and eyebrow spasm all decreased substantially over the first ten days following the initial injection. Patients with essential blepharospasm, hemifacial spasm, or previous surgery all responded in a similar fashion. This beneficial effect was transient, however, and additional treatment was required for sustained relief. Twenty-five patients received multiple injections with a mean interval of 65 days. Results of second and third injections were similar to the first in rapidity of onset and duration of effect. Complications were local, mild, and transient, and no systemic side effects were noted.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970122     DOI: 10.1016/0002-9394(85)90228-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

Review 1.  Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases.

Authors:  S Jitpimolmard; S Tiamkao; M Laopaiboon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

2.  Management of blepharospasm.

Authors:  R R Waller; R H Kennedy; J W Henderson; K R Kesty
Journal:  Trans Am Ophthalmol Soc       Date:  1985

3.  Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression.

Authors:  Bo Yin; Bin Peng; Ying Luo; Shanghua Fan; Ting Xiao; Xiaoli Zou; Hongjuan Dong
Journal:  Neuropsychiatr Dis Treat       Date:  2021-08-17       Impact factor: 2.570

4.  Blepharospasm: a review of 264 patients.

Authors:  F Grandas; J Elston; N Quinn; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

5.  Beneficial effect of botulinum A toxin in blepharospasm: 16 months' experience with 16 cases.

Authors:  S Maurri; S Brogelli; G Alfieri; F Barontini
Journal:  Ital J Neurol Sci       Date:  1988-08

6.  Botulinum toxin paralysis of the orbicularis oculi muscle. Types and time course of alterations in muscle structure, physiology and lid kinematics.

Authors:  A K Horn; J D Porter; C Evinger
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

Review 7.  Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm.

Authors:  Bettina Wabbels; Wolfgang H Jost; Peter Roggenkämper
Journal:  J Neural Transm (Vienna)       Date:  2011-01-09       Impact factor: 3.575

Review 8.  Botulinum Toxin in Movement Disorders: An Update.

Authors:  Charenya Anandan; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-01-08       Impact factor: 4.546

9.  Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A-30 Years of Experience in a Tertiary Care Center.

Authors:  Bettina Wabbels; Rolf Fimmers; Peter Roggenkämper
Journal:  Toxins (Basel)       Date:  2022-02-07       Impact factor: 4.546

Review 10.  Botulinum toxin physiology in focal hand and cranial dystonia.

Authors:  Barbara Illowsky Karp
Journal:  Toxins (Basel)       Date:  2012-11-20       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.